Effects of Y-27632, a selective Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats

Biochemical Pharmacology

Volumn 69, Issue 1, 2005, Pages 49-58

  Demiryürek, Şeniz ^a   Kara, Ali F ^b   Çelik, Ahmet ^b   Tarakçioǧlu, Mehmet ^b   Baǧci, Cahit ^b   Demiryürek, Abdullah T ^b  

^a GAZI UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Arrhythmias; Cardioprotection; Infarct size; Preconditioning; Rho kinase; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CARBACHOL; LACTIC ACID; MALONALDEHYDE; PHOSPHOTRANSFERASE INHIBITOR; RHO KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; LACTATE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMIDES; ANESTHESIA; ANIMALS; ENZYME INHIBITORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RATS; RATS, WISTAR;

EID: 9944250488     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.09.016     Document Type: Article

References (43)

1. A.P. Somlyo, and A.V. Somlyo Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II J Physiol 522 2000 177 185
2. H. Shimokawa Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases J Cardiovasc Pharmacol 39 2002 319 327
3. N. Kobayashi, S. Horinaka, S. Mita, S. Nakano, T. Honda, and K. Yoshida Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts Cardiovasc Res 55 2002 757 767
4. A. Takahara, A. Sugiyama, Y. Satoh, M. Yoneyama, and K. Hashimoto Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model Eur J Pharmacol 460 2003 51 57
5. A. Sugiyama, Y. Yatomi, A. Takahara, Y. Satoh, and K. Hashimoto Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations Jpn J Pharmacol 88 2002 359 361
6. T. Utsunomiya, S. Satoh, I. Ikegaki, Y. Toshima, T. Asano, and H. Shimokawa Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina Brit J Pharmacol 134 2001 1724 1730
7. S. Sato, I. Ikegaki, T. Asano, and H. Shimokawa Antiischemic properties of fasudil in experimental models of vasospastic angina Jpn J Pharmacol 87 2001 34 40
8. S. Satoh, Y. Ueda, M. Koyanagi, T. Kadokami, M. Sugano, and Y. Yoshikawa Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure J Mol Cell Cardiol 35 2003 59 70
9. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
10. S. Altug, A.T. Demiryurek, K.A. Kane, and I. Kanzik Evidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts Brit J Pharmacol 130 2000 125 131
11. V. Richard, N. Kaeffer, C. Tron, and C. Thuillez Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion Circulation 89 1994 1254 1261
12. E. Murphy Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection Circ Res 94 2004 7 16
13. W. Bao, E. Hu, L. Tao, R. Boyce, R. Mirabile, and D.T. Thudium Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury Cardiovasc Res 61 2004 548 558
14. M.J.A. Walker, M.J. Curtis, D.J. Hearse, R.W.F. Campbell, M.J. Janse, and D.M. Yellon The Lambeth conventions: guidelines for the study of arrhythmias in ischemia, infarction and reperfusion Cardiovasc Res 22 1988 447 455
15. A.T. Demiryurek, G. Yildiz, S. Esiyok, and S. Altug Protective effects of poly (ADP-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated hearts Pharmacol Res 45 2002 189 194
16. K. Ytrehus, Y. Liu, A. Tsuchida, T. Miura, G.S. Liu, and X.M. Yang Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing Am J Physiol 267 1994 H2383 H2390
17. F. Yamaguchi, Y. Nasa, K. Yabe, S. Ohba, Y. Hashizume, and H. Ohaku Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heart Heart Vessels 12 1997 74 83
18. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
19. A.M. Jentzsch, H. Bachmann, P. Furst, and H.K. Biesalski Improved analysis of malondialdehyde in human body fluids Free Radic Biol Med 20 1996 251 256
20. S. Sanada, H. Asanuma, O. Tsukamoto, T. Minamino, K. Node, and S. Takashima Protein kinase a as another mediator of ischemic preconditioning independent of protein kinase C Circulation 110 2004 51 57
21. A. Sugiyama, A. Takahara, Y. Yatomi, Y. Satoh, Y. Nakamura, and K. Hashimoto Constitutional rho-kinase regulates atrioventricular nodal conduction and ventricular repolarization of the canine heart J Cardiovasc Pharmacol 41 2003 930 933
22. N. Katsumata, H. Shimokawa, M. Seto, T. Kozai, T. Yamawaki, and K. Kuwata Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β Circulation 96 1997 4357 4363
23. Y. Yamamoto, I. Ikegaki, Y. Sasaki, and T. Uchida The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit J Cardiovasc Pharmacol 35 2000 203 211
24. A. Masumoto, M. Mohri, H. Shimokawa, L. Urakami, M. Usui, and A. Takeshita Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina Circulation 105 2002 1545 1547
25. M. Hendrikx, Y. Toshima, K. Mubagwa, and W. Flameng Muscarinic receptor stimulation by carbachol improves functional recovery in isolated, blood perfused rabbit heart Cardiovasc Res 27 1993 980 989
26. M. Endoh Dual inhibition of myocardial function through muscarinic and adenosine receptors in the mammalian heart J Appl Cardiol 2 1987 213 230
27. J.D. Thornton, G.S. Liu, and J.M. Downey Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism J Mol Cell Cardiol 25 1993 311 320
28. O.I. Pisarenko, V.S. Shulzhenko, and I.M. Studneva Metabolic and functional effects of carbachol and ischaemic preconditioning in rat isolated heart Clin Exp Pharmacol Physiol 26 1999 26 31
29. ATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide Am J Physiol 271 1996 H23 H28
30. J. Mair, F. Dienstl, and B. Puschendorf Cardiac troponin T in the diagnosis of myocardial injury Crit Rev Clin Lab Sci 29 1992 31 57
31. 2+ sensitization of myosin light chain phosphorylation in smooth muscle Biochem J 318 1996 469 475
32. 2+-sensitization of smooth muscle FEBS Lett 440 1998 183 187
33. T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Eto, and K. Morishige Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm Arterioscler Thromb Vasc Biol 23 2003 2209 2214
34. C. Barandier, X.F. Ming, S. Rusconi, and Z. Yang PKC is required for activation of ROCK by RhoA in human endothelial cells Biochem Biophys Res Commun 304 2003 714 719
35. S. Sakurada, H. Okamoto, N. Takuwa, N. Sugimoto, and Y. Takuwa Rho activation in excitatory agonist-stimulated vascular smooth muscle Am J Physiol 281 2001 C571 C578
36. S. Soylemez, A.T. Demiryurek, and I. Kanzik Involvement of tyrosine kinase in peroxynitrite-induced preconditioning in rat isolated heart Eur J Pharmacol 464 2003 163 169
37. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem J 351 2000 95 105
38. M. Eto, T. Kitazawa, M. Yazawa, H. Mukai, Y. Ono, and D.L. Brautigan Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms J Biol Chem 276 2001 29072 29078
39. T.J. Bivalacqua, H.C. Champion, M.F. Usta, S. Cellek, K. Chitaley, and R.C. Webb RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction Proc Natl Acad Sci USA 101 2004 9121 9126
40. S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, and J.B. Michel Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases Circ Res 90 2002 420 427
41. M. Takemoto, J. Sun, J. Hiroki, H. Shimokawa, and J.K. Liao Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase Circulation 106 2002 57 62
42. 2 radicals during reperfusion after prolonged myocardial ischemia Am J Physiol 280 2001 2649 2657
43. A. Kawaguchi, M. Ohmori, K. Harada, S. Tsuruoka, K. Sugimoto, and A. Fujimura The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes Eur J Pharmacol 403 2000 203 208